Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(15%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
9
69%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(5)
Other(5)

Detailed Status

Completed5
unknown5
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting215%
completed538%
not_yet_recruiting18%
unknown538%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
PROCEDURE
Total Trials
13